A patient with prediabetes and hypertension is on a regimen including furosemide, carvedilol, losartan, and lisinopril. Given the patient's BMI of 28 kg/m2 and diastolic blood pressure of 79 mmHg, which clinical interpretation is most appropriate regarding their cardiovascular risk?
The current medication regimen is inappropriate due to potential drug interactions between carvedilol and furosemide. The patient's BMI is within normal range, so weight management is not a priority. The patient's blood pressure is well-controlled, but their BMI indicates a need for weight management to reduce cardiovascular risk. The diastolic blood pressure is elevated, suggesting the need for additional antihypertensive therapy.